The incidence of malignant melanoma in the United States: Issues as we approach the 21st century

Journal of the American Academy of Dermatology

Volumn 34, Issue 5 I, 1996, Pages 839-847

  Rigel, Darrell S ^a   Friedman, Robert J ^b   Kopf, Alfred W ^b  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; DEMOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MELANOMA; PRIORITY JOURNAL; REVIEW; UNITED STATES;

EID: 0029984475     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(96)90041-9     Document Type: Article

References (42)

1. Kopf AW, Rigel DS, Friedman RJ. The rising incidence and mortality rate of malignant melanoma. J Dermatol Surg Oncol 1982;8:760-1.
2. Rigel DS, Kopf AW, Friedman RJ. The rate of malignant melanoma in the United States: Are we making an impact? [Editorial] J AM ACAD DERMATOL 1987;17:1050-23.
3. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J AM ACAD DERMATOL 1994;30:774-8.
4. Parker SL, Tong T, Bolden S, et al. Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27.
5. Devesa SS, Silverman BT, Young UL, et al. Cancer incidence and mortality trends among whites in the U.S. 1947-84. J Natl Cancer Inst 1987;79:701-77.
6. Devesa SS, Blot WJ, Stone BJ, et al. Recent cancer trends in the United States. J Natl Cancer Inst 1995;87:175-82.
7. Koh HK, Geller AC, Miller DR, et al. Early detection of melanoma: an ounce of prevention may be a ton of work. J AM ACAD DERMATOL 1993;28:645-7.
8. MacKie R, Hunter JA, Aitchison TC. Cutaneous malignant melanoma, Scotland, 1979-1989. Lancet 1992;339:971-5.
9. MacLennan R, Green AC, McLeod GR, et al. Increasing incidence of cutaneous melanoma in Queensland, Austria. J Natl Cancer Inst 1992;84:1427-32.
10. Pehamberger H, Binder M, Knollmayer S, et al. Immediate effects of a public education campaign on prognostic features of melanoma. J AM ACAD DERMATOL 1993; 29:106-9.
11. Grin CS, Rigel DS, Friedman RJ. Worldwide incidence of malignant melanoma. In: Balch CM, Houghton A, Milton G, et al, eds. Cutaneous melanoma. Philadelphia: JB Lippincott, 1992:28-37.
12. Melia J, Frost T, Graham-Brown R, et al. Problems with registration of malignant melanoma in England. Br J Cancer 1995;72:224-8.
13. Ceilley R. Melanoma trends in Iowa [Abstract]. Proceedings of the Pacific Dermatologic Association Annual Meeting, 1991.
14. Glocker-Reis LA, Miller BA, Hankey BF, et al, eds. SEER Cancer Statistics Review, 1973-1991: tables and graphs. National Institutes of Health Publication No. 94-2789. Bethesda, Md: National Cancer Institute, 1994.
15. Koh HK, Clapp RW, Barnett JM, et al. Systematic underreporting of cutaneous malignant melanoma in Massachusetts. J AM ACAD DERMATOL 1991;24:545-50.
16. Koh HK, Geller A, Miller DR, et al. Underreporting of cutaneous melanoma in cancer registries nationwide [Letter]. J AM ACAD DERMATOL 1992;27:1035-6.
17. Salopek TG, Marghoob AA, Slade JM, et al. An estimate of the incidence of malignant melanoma in the United States based upon a survey of the members of the American Academy of Dermatology. Dermatol Surg 1995; 21:301-5.
18. Wender RC. Barriers to effective skin cancer detection. Cancer 1995;75:691-8.
19. Van der Esch EP, Muir CS, Nectoux J. Temporal change in diagnostic criteria as a cause of the increase of malignant melanoma over time is unlikely. Int J Cancer 1991;47:483-90.
20. Phillipp R, Hastings A, Briggs J, et al. Are malignant melanoma time trends explained by changes in histopathology criteria for classifying pigmented skin lesions? J Epidemiol Community Health 1987;42:14-6.
21. Balch CM, Soong S, Shaw HM, et al. An analysis of prognostic factors in 8500 patients with cutaneous melanoma. In: Balch CM, Houghton A, Milton G, et al, eds. Cutaneous melanoma. Philadelphia: JB Lippincott, 1992:165-87.
22. Herd RM, Cooper EJ, Hunter JA, et al. Cutaneous malignant melanoma: publicity, screening clinics and survival - the Edinburgh experience. Br J Dermatol 1995;132:563-70.
23. Burton RC, Coates MS, Hersey P, et al. An analysis of a melanoma epidemic. Int J Cancer 1993;55:765-70.
24. Schaart EM, Garbe C, Orfanos C. Disappearance of the ozone layer and skin cancer: attempt at risk assessment. Hautarzt 1993;44:63-8.
25. Armstrong BK, Kricker A. Cutaneous melanoma. Cancer Surv 1994;20:219-40.
26. Lew RA, Sober AJ, Cook N, et al. Sun exposure habits in patients with cutaneous melanoma: a case control study. J Dermatol Surg Oncol 1983;12:981-6.
27. Brown J, Kopf AW, Rigel DS, et al. Malignant melanoma in World War II veterans Int J Dermatol 1984;23:661-3.
28. Staehelin J, Blumthaler M, Ambach W, et al. Skin cancer and the ozone shield. Lancet 1990;336:502.
29. Nagy K. New database allows researchers to evaluate cancer care costs. J Natl Cancer Inst 1993;85:351-3.
30. Ramsay DL, Fox AB. The ability of primary care physicians to recognize the common dermatoses. Arch Dermatol 1981;117:620-2.
31. Koh HK, Miller DR, Geller AC, et al. Who discovers melanoma? J AM ACAD DERMATOL 1992;26:914-9.
32. Friedman RJ, Rigel DS, Silverman M, et al. Malignant melanoma in the 1990's: the continued importance of early detection and the role of physician examination and self-examination of the skin. CA Cancer J Clin 1991;41: 201-26.
33. Spencer JM, Amonette RA. Indoor tanning: risk, benefits, and future trends. J AM ACAD DERMATOL 1995;33:288-98.
34. Marks R. Skin cancer control in the 1990s, from slip! slap! slop! to sun smart. Austrailas J Dermatol 1990;31:1-4.
35. Slue W, Kopf AW, Rivers JK. Total body photographs of dysplastic nevi. Arch Dermatol 1988;124:1239-43.
36. Green A, Martin N, Pfitzner J, et al. Computer image analysis in the diagnosis of melanoma. J AM ACAD DERMATOL 1994;31:958-64.
37. Binder M, Schwartz M, Winkler A, et al. Epiluminescence microscopy: a useful tool for the diagnosis of pigmented skin lesions for formally trained dermatologists. Arch Dermatol 1995;131:286-91.
38. Stoltz W, Braun-Falco O, Bilek P, et al. Color atlas of dermatoscopy. London: Blackwell Scientific, 1994.
39. Koh HK, Norton LA, Geller AC, et al. Evaluation of a national skin cancer early detection and screening program. Pub Health Rep (In press.)
40. MacKie RM, Freudenberger T, Aitchison TC. Personal risk factor chart for cutaneous melanoma. Lancet 1989;2:487-90.
41. Rigel DS. Epidemiology and prognostic factors in malignant melanoma. Ann Plast Surg 1992;28:7-8.
42. Seiffert J. Underreporting of melanoma. J Natl Cancer Inst 1992;84:289.